Table 2. The Overall Prevalence of Metabolic Syndrome in the Iranian Adult Population According to Different Criteria and Sex Using Random Effect Meta-Analysis of Data From Population-based Studies.
| Criteria | Extracted articles (n) | Sample size (n) | Prevalence (%) | CI 95% |
|---|---|---|---|---|
| ATP III | ||||
| Male | 15 | 24,760 | 27.7 | 21.8 - 33.6 |
| Female | 19 | 32,046 | 43.1 | 37.9 - 48.4 |
| Total | 17 | 54,043 | 36.9 | 32.7 - 41.2 |
| Heterogeneity ATP III (I-square) | ||||
| Male | 99.9% | P < 0.001 | ||
| Female | 99.8% | P < 0.001 | ||
| Total | 99.8% | P < 0.001 | ||
| IDF | ||||
| Male | 6 | 9,874 | 30.7 | 23.9 - 37.5 |
| Female | 6 | 12,498 | 42.0 | 37.4 - 46.6 |
| Total | 7 | 23,774 | 34.6 | 31.7 - 37.6 |
| Heterogeneity IDF (I-square) | ||||
| Male | 99.6% | P < 0.001 | ||
| Female | 99% | P < 0.001 | ||
| Total | 98.9% | P < 0.001 | ||
| JIS | ||||
| Male | 1 | 1,856 | 45.7 | 44.6 - 46.8 |
| Female | 2 | 2,815 | 37.3 | 32.4 - 42.2 |
| Total | 4 | 10,385 | 41.5 | 29.8 - 53.2 |
| Heterogeneity JIS (I-square) | ||||
| Male | - | |||
| Female | 99.9% | P < 0.001 | ||
| Total | 99.8% | P < 0.001 |